Preventing adhesions after myomectomy surgery
Official title: Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy
Run by University Hospital, Ghent · NCT05683041 · Data updated 2026-11-12
This study is testing whether a special gel used during myomectomy surgery can help prevent scar tissue from forming in women aged 18 to 45, which could improve their chances of getting pregnant later.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 1 site (Ghent) |
| Status | Recruiting |
| Started | February 22, 2023 |
| Main results expected | January 2029 |
| Study ends | January 2030 |
| Registry record updated | August 20, 2026 |
| Trial ID | NCT05683041 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18 to 45 with specific types of myomas scheduled for myomectomy and without pre-existing intrauterine adhesions.
✕Probably not a fit
Patients who are pregnant, have endometritis, or are undergoing combined operative hysteroscopy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of an intrauterine gel in preventing intrauterine adhesions following laparoscopic or laparotomic myomectomy in women aged 18 to 45 with specific types of myomas. It is a double-blind, randomized controlled pilot trial where participants will either receive the gel or a control treatment during their surgery. A follow-up hysteroscopy will be conducted three months post-surgery to assess adhesion formation. The study aims to improve fertility outcomes by reducing postoperative complications associated with myomectomy.
Why it matters
Potential benefit: If successful, this study could significantly enhance fertility prospects for women undergoing myomectomy by reducing the risk of intrauterine adhesions.
How similar studies have gone: Other studies have shown promise in using similar antiadhesion methods, but this specific approach with Hyalobarrier® gel is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age between 18 and 45 years. * intramurale and/or subserosal myoma (FIGO 3-6), and/or hybrid myoma (with a connection to the endometrium and serosa (FIGO 2-5), who are scheduled for laparoscopic / laparotomic myomectomy. * absence of intra-uterine adhesions on preoperative diagnostic hysteroscopy Exclusion Criteria: * pregnancy. * laparoscopic or laparotomic myomectomy in combination with an operative hysteroscopy. * presence of endometritis. * other antiadhesion methods
Where it's running
-
University Hospital Ghent
Ghent, Belgium Recruiting
Study contacts
- Study coordinator: Steffi Van Wessel, Dr.
- Email: studieco.vrouwenkliniek@uzgent.be
- Phone: 093320758
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Uterine artery ligation versus pericervical tourniquet to reduce bleeding during open myomectomy
This trial will test whether tying the uterine arteries or using a pericervical tourniquet better reduces blood loss during open myomectomy for women with symptomatic uterine fibroids.
-
Ergometrine versus carbetocin to reduce bleeding during abdominal myomectomy
This study will see if injecting ergometrine or carbetocin into the uterus during abdominal myomectomy reduces blood loss in women having surgery for symptomatic fibroids.
-
Temporary Clamping of Uterine and Ovarian Vessels During Minimally Invasive Myomectomy
This study tests whether temporarily blocking blood flow from the uterine and ovarian arteries during minimally invasive myomectomy reduces blood loss for patients with large or multiple fibroids.
-
Preventing bleeding during myomectomy with misoprostol
This will test whether giving misoprostol before myomectomy reduces surgical bleeding in women aged 18–43 having surgery for symptomatic uterine fibroids.
-
Comparing Terlipressin and Carbetocin for reducing blood loss during myomectomy
This study is testing whether injections of Terlipressin or Carbetocin can help reduce blood loss during surgery to remove fibroids in women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.